Fate Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Fate Therapeutics | 8-K: Current report
Fate Therapeutics | 8-K: Current report
Fate Therapeutics | 8-K: Current report
Fate Therapeutics | 8-K: Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
Fate Therapeutics | 8-K: Current report
Fate Therapeutics | DEF 14A: Definitive information statements
Fate Therapeutics | DEFA14A: Others
Fate Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Fate Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Fate Therapeutics | 8-K: Current report
Fate Therapeutics | 8-K: Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Fate Therapeutics | 8-K: Current report
Fate Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Fate Therapeutics | 8-K: Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
Fate Therapeutics | 8-K: Current report
Fate Therapeutics | 8-K: Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
Fate Therapeutics | 8-K: Current report
Fate Therapeutics | 8-K: Current report
Fate Therapeutics | 8-K: Current report
No Data